Add a listing
    Add a listing

    Loyal

      we're developing drugs that treat the underlying causes of aging in dogs.

    General
    • Headquarters

      San Francisco, California, United States of America

    • Founders & Team

      Celine Halioua

    • Year Founded

      2019

    • Company type

      Private company

    • Funding stage

      Seed

    • Total funding ($M)

      11.0

    • Investors

      The Longevity Fund, First Round, Collaborative Fund, Village, Box Group

    Technical Details
    • Disease indication

      Aging (in dogs)

    • Product modality

      drugs

    • Clinical stage

      Pre-clinical

    Who We Are

    Loyal is a seed stage company developing drugs to help dogs live longer, healthier lives. We see aging as a disease that is able to be slowed and improved with medicines. Loyal was spun out of Laura Deming’s The Longevity Fund and is well funded by top venture capitalists and angels.

    Categories

    How much is an extra decade of life worth to you? Make a bet on longevity science today.

    Donate to Impetus Grants

    You May Also Be Interested In